{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:45:14Z","timestamp":1787024714201,"version":"build-2736575974"},"reference-count":31,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2019,4,15]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Adrenal incidentalomas are diagnosed incidentally during radiological screenings\nand require endocrinological investigations for hormonal activity and malignancy. In certain studies, it\nhas been reported that non-functional incidentalomas can be associated with high adipocytokines levels\naffecting the insulin resistance just like the adipose tissue with metabolic syndrome. Here, we studied\nserum adipocytokine levels including leptin, resistin, visfatin, omentin 1 and adiponectin in subjects\nwith non-functional adrenal incidentaloma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Seventy-seven (77) patients (Female 57; Male 20) with non-functional adrenal incidentaloma\n(NFAI) were enrolled in the study. All patients\u2019 past medical history, physical examination including\nBody Mass Index (BMI) and waist circumference were performed. The patients\u2019 demographic,\nradiologic, hormonal and biochemical parameters were recorded. To compare the parameters, a control\ngroup (CG) (n=30) was formed from healthy volunteers. Both groups were matched for age, gender,\nwaist circumference and BMI. Serum adipocytokines including leptin, resistin, visfatin, omentin 1 and\nadiponectin were measured quantitatively by ELISA. Fasting plasma glucose, insulin, sodium, potassium,\ncortisol, adrenocorticotropic hormone (ACTH), lipid profiles, and dehidroepiandrostenedion\nsulphate (DHEAS) were measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Mean age of the patients was 52.2\u00b110.4 years. BMI and waist circumference of NFAI patients\nwere 26.2\u00b13.28 kg\/m2 and 90.2 \u00b17.5cm, respectively. The mean age of the control group was\n48.0\u00b18.16. BMI and waist circumference values for the control group were 25.3\u00b13.5 kg\/m2 and\n88.3\u00b19.6 cm, respectively. When both groups were compared for age, gender, BMI and waist circumference\nwere non-significant (p&gt;0.05). Serum fasting insulin, total cholesterol, LDL, triglyceride levels\nof the NFAI group were significantly higher than CG (p&lt;0.05). The insulin resistance index (HOMAIR)\nvalues of the NFAI subjects were found to be higher than CG (2.5\u00b11.37, 1.1\u00b10.3 p=0.00). Resistin\nlevel of NFAI group was also found to be higher than CG [286.6 ng\/L vs. 197 ng\/L; (P=0,00)], respectively.\nLeptin levels of NFAI were significantly higher than CG [441.1 ng\/mL vs. 186.5 ng\/mL;\n(P=0.00)] respectively. Adiponectin levels were significantly reduced in the NFAI group than in the\nCG [10.7 mg\/L vs. 30.8 mg\/L; (P=0.00)]. Comparision of visfatin and omentin levels was nonsignificant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In this study on subjects with non-functional adrenal incidentaloma, we found not only\nsignificantly decreased serum adiponectin levels but also increased leptin, resistin levels as well as\ndyslipidemia, hypertension and high insulin resistance index. All of which could affect insulin resistance\nand cardiovascular risk factors. The underlying mechanisms of these findings are unknown,\nhence further studies are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1871530318666181009112042","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T07:33:29Z","timestamp":1539243209000},"page":"326-332","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters"],"prefix":"10.2174","volume":"19","author":[{"given":"Gamze","family":"Akkus","sequence":"first","affiliation":[{"name":"Endocrinology Department, Cukurova University, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehtap","family":"Evran","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Cukurova University, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Sert","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Cukurova University, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Tetiker","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Cukurova University, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.beem.2009.04.001","volume":"23","author":"Terzolo M.","year":"2009","unstructured":"Terzolo M, Bovio S, Pia A, Reimondo G, Angeli A.  Management of adrenal incidentaloma.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=2","first-page":"637","volume":"85","author":"Mantero F.","year":"2000","unstructured":"Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Al\u00ec A, Giovagnetti M, Opocher G, Angeli A.  A survey on adrenal incidentaloma in Italy.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/07435800.2013.840653","volume":"39","author":"Arduc A.","year":"2014","unstructured":"Arduc A, Isik S, Ozuguz U, Tutuncu YA, Kucukler FK, Ozcan HN, Berker D, Guler S.  Relationship between thyroid nodules and non-functioning adrenal incidentalomas and their association with insulin resistance.","journal-title":"Endocr Res"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.12659\/MSM.897714","volume":"22","author":"Evran M.","year":"2015","unstructured":"Evran M, Akkus G, Berk Bozdo\u011fan \u0130, Deniz A, Gok M, Deniz A, Sert M, Tetiker T.  Carotid intima-media thickness as the cardiometabolic risk indicator in patients with nonfunctional adrenal mass and metabolic syndrome screening.","journal-title":"Med Sci Monit"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.metabol.2010.01.007","volume":"59","author":"Peppa M.","year":"2010","unstructured":"Peppa M, Boutati E, Koliaki C, Garoflos E, Raptis SA.  Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: A cause-effect relationship?","journal-title":"Metabolism"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti K.G.","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM.  Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity.","journal-title":"Circulation"},{"key":"ref=7","first-page":"11","volume":"5","author":"Cardinali D.P.","year":"2016","unstructured":"Cardinali DP, Hardeland R.  Inflammaging, metabolic syndrome and melatonin: A call for treatment studies.","journal-title":"Neuroendocrinology"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/eje.1.02338","volume":"156","author":"Norata G.D.","year":"2007","unstructured":"Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL.  Plasma resistin levels correlate with determinants of the metabolic syndrome.","journal-title":"Eur J Endocrinol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2009.07.031","volume":"314","author":"Maury E.","year":"2010","unstructured":"Maury E, Brichard SM.  Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome.","journal-title":"Mol Cell Endocrinol"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/ijd.12706","volume":"54","author":"Campanati A.","year":"2015","unstructured":"Campanati A, Ganzetti G, Maurizio M.  Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-\u03b1 inhibitors: results of a retrospective analysis.","journal-title":"Int J Dermatol"},{"key":"ref=11","first-page":"177","volume":"84","author":"Landeros-Olvera E.","year":"2014","unstructured":"Landeros-Olvera E, L\u00f3pez-Alvarenga JC, Nava-Gonz\u00e1lez EJ, Gallegos-Cabriales E, Lavalle-Gonz\u00e1lez F, Bastarrachea RA, Salazar Gonz\u00e1lez BC.  Cardiovascular exercise on obese women: effects on adiponectine, leptine, and tumour necrosis factor-alpha.","journal-title":"Arch Cardiol"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","volume":"290","author":"Yang R.Z.","year":"2006","unstructured":"Yang RZ, Lee MJ, Hu H.  Identification of omentin as a novel depot-specificadipokine in human adipose tissue: possible role in modulating insulin action.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1475-2840-13-84","volume":"13","author":"Narumi T.","year":"2014","unstructured":"Narumi T, Watanabe T, Kadowaki S, Kinoshita D, Yokoyama M, Honda Y.  Otaki. Y.; Nishiyama. S.; Takahashi. H.; Arimoto. T.; Shishido. T.; Miyamoto. T.; Kubota. I. Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure.","journal-title":"Cardiovasc Diabetol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/jc.2013-4064","volume":"99","author":"Androulakis I.I.","year":"2014","unstructured":"Androulakis II, Kaltsas GA, Kollias GE, Markou AC, Gouli AK, Thomas DA, Alexandraki KI, Papamichael CM, Hadjidakis DJ, Piaditis GP.  Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=15","first-page":"5301","volume":"86","author":"Garrapa G.G.","year":"2001","unstructured":"Garrapa GG, Pantanetti P, Arnaldi G, Mantero F, Faloia E.  Body composition and metabolic features in women with adrenal incidentaloma or Cushing\u2019s syndrome.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0140-6736(02)07281-1","volume":"359","author":"McTernan C.L.","year":"2002","unstructured":"McTernan CL, McTernan PG, Harte AL, Levick P, Barnett A, Kumar S.  Resistin, central obesity, and type 2 diabetes.","journal-title":"Lancet"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"e0138480","DOI":"10.1371\/journal.pone.0138480","volume":"10","author":"Wittenbecher C.","year":"2015","unstructured":"Wittenbecher C, di Giuseppe R, Biemann R, Menzel J, Arregui M, Hoffmann J, Aleksandrova K, Boeing H, Isermann B, Schulze MB, Weikert C.  Reproducibility of retinol binding protein 4 and omentin-1 measurements over a four months period: A reliability study in a cohort of 207 apparently healthy participants.","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jnutbio.2016.03.017","volume":"33","author":"Masquio D.C.","year":"2016","unstructured":"Masquio DC, Pian-Ganen A, Oyama LM, Campos RM, Santamarina AB, de Souza GI, Gomes AD, Moreira RG, Corgosinho FC, do Nascimento CM, Tock L, Tufik S, de Mello MT, D\u00e2maso AR.  The role of free fatty acids in the inflammatory and cardiometabolic profile in adolescents with metabolic syndrome engaged in interdisciplinary therapy.","journal-title":"J Nutr Biochem"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1210\/en.2013-1523","volume":"155","author":"D\u2019souza A.M.","year":"2014","unstructured":"D\u2019souza AM, Asadi A, Johnson JD, Covey SD, Kieffer TJ.  Leptin deficiency in rats results in hyperinsulinemia and impaired glucose homeostasis.","journal-title":"Endocrinology"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1111\/bph.13619","volume":"174","author":"Woodward L.","year":"2017","unstructured":"Woodward L, Akoumionakis I, Antonioades C.  Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.","journal-title":"Br J Pharmacol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","volume":"307","author":"Fukuhara A.","year":"2005","unstructured":"Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I.  Visfatin1 A protein secreted by visceral fat that mimics the effects of insulin.","journal-title":"Science"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"e0162247","DOI":"10.1371\/journal.pone.0162247","volume":"11","author":"Gradidge P.","year":"2016","unstructured":"Gradidge P, Norris S, Jaff NG.  Metabolic and body composition risk factors associated with metabolic syndrome in a cohort of women with a high prevalence of cardiometabolic disease.","journal-title":"PLoS One"},{"key":"ref=23","first-page":"1","volume":"23","author":"Wolk K.","year":"2016","unstructured":"Wolk K, Sabat R.  Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.","journal-title":"Rev Endocr Metab Disord"},{"key":"ref=24","first-page":"662","volume":"17","author":"Mirfeizi Z.","year":"2014","unstructured":"Mirfeizi Z, Noubacht Z, Rezaie AE, Jokar MH, Sarabi ZS.  Plasma levels of leptin and visfatin in rheumatoid arthritis patients; is there any relationship with joint damage?","journal-title":"Iran J Basic Med Sci"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40618-014-0232-0","volume":"38","author":"Masserini B.","year":"2015","unstructured":"Masserini B, Morelli V, Palmieri S, Eller-Vaicinicher C, Zhuokuskaya V, Cairoli E, Orsi E, Beck-Peccoz P, Spada A, Chiodini I.  Lipid abnormalities in patients with adrenal incidentalomas: role of subclinical hypercortisolism and impaired glucose metabolism.","journal-title":"J Endocrinol Invest"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-15-0566","volume":"173","author":"Preogamvros I.","year":"2016","unstructured":"Preogamvros I, Vassiliadi DA, Karapanou O, Botoulo E, Tzanela M, Tsagarakis S.  Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas.","journal-title":"Eur J Endocrinol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.tem.2015.07.010","volume":"26","author":"Muscogiuri G.","year":"2015","unstructured":"Muscogiuri G, Colao A, Orio F.  Insulin-mediated diseases: Adrenal mass and polycystic ovary syndrome.","journal-title":"Trends Endocrinol Metab"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.metabol.2006.12.018","volume":"56","author":"Ermetici F.","year":"2007","unstructured":"Ermetici F, Malavazos AE, Corbetta S, Morricone L, Corsi MM, Ambrosi B.  Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma.","journal-title":"Metabolism"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40618-014-0106-5","volume":"37","author":"Tuna M.M.","year":"2014","unstructured":"Tuna MM, Imga NN, Dogan B, Y\u0131lmaz FM, Top\u00e7uo\u011flu C, Akbaba G, Berker D, G\u00fcler S.  Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis.","journal-title":"J Endocrinol Invest"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00508-011-0064-2","volume":"123","author":"Lazurova I.","year":"2011","unstructured":"Lazurova I, Spisakova D, Wagnerova H.  Clinically silent adrenal adenomas - their relation to the metabolic syndrome and to GNB3 C825T gene polymorphism.","journal-title":"Wien Klin Wochenschr"},{"key":"ref=31","first-page":"8519362","volume":"2016","author":"Unal A.","year":"2016","unstructured":"Unal A, Ayt\u00fcrk S, Aldemir D.  Serum adiponectin level as a predictor of subclinical Cushing\u2019s syndrome in patients with adrenal incidentaloma.","journal-title":"Int J Endocrinol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/166075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T08:45:01Z","timestamp":1562921101000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/166075\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4,15]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530318666181009112042","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}